John S. Patton

2006

In 2006, John S. Patton earned a total compensation of $822.4K as Chief Research Fellow at Nektar Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$131,060
Option Awards$103,412
Salary$286,534
Stock Awards$292,289
Other$9,071
Total$822,366

Patton received $292.3K in stock awards, accounting for 36% of the total pay in 2006.

Patton also received $131.1K in non-equity incentive plan, $103.4K in option awards, $286.5K in salary and $9.1K in other compensation.

Rankings

In 2006, John S. Patton's compensation ranked 3,516th out of 7,022 executives tracked by ExecPay. In other words, Patton earned more than 49.9% of executives.

ClassificationRankingPercentile
All
3,516
out of 7,022
50th
Division
Manufacturing
1,129
out of 2,413
53rd
Major group
Chemicals And Allied Products
257
out of 673
62nd
Industry group
Drugs
166
out of 518
68th
Industry
Pharmaceutical Preparations
131
out of 355
63rd
Source: SEC filing on April 28, 2008.

Patton's colleagues

We found six more compensation records of executives who worked with John S. Patton at Nektar Therapeutics in 2006.

2006

Ajit Gill

Nektar Therapeutics

Chief Executive Officer

2006

Robert Chess

Nektar Therapeutics

Chief Executive Officer

2006

Ajay Bansal

Nektar Therapeutics

Chief Financial Officer

2006

David Johnston

Nektar Therapeutics

Former Senior Vice President Research and Development

2006

Louis Drapeau

Nektar Therapeutics

Chief Financial Officer

2006

Nevan Elam

Nektar Therapeutics

Senior Vice President and Head of the Pulmonary Business Unit

You may also like